MedTrace Logo

Efficacy and Safety Study of the Effect of Dose-Titration of Prucalopride for The Treatment of Chronic Constipation

NCT00577018 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 755

Last updated 2008-05-29

No results posted yet for this study

Summary

The purpose of this study is to determine the safety profile of 4 mg prucalopride in the treatment of chronic constipation.

Conditions

Interventions

DRUG

Prucalopride

4 mg o.d.

DRUG

Prucalopride

1 mg o.d. for 2 days, 2 mg o.d. for 2 days and 4 mg o.d. thereafter

OTHER

Placebo

o.d.

Sponsors & Collaborators

  • Movetis

    lead INDUSTRY

Principal Investigators

  • John F Johanson, MD, MSc · Private Practice

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
1998-08-31
Primary Completion
1999-09-30
Completion
1999-09-30

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00577018 on ClinicalTrials.gov